Artificial Metalloenzymes Based on the Biotin–Streptavidin Technology: Challenges and Opportunities by Heinisch, Tillmann & Ward, Thomas R.
  
This document is confidential and is proprietary to the American Chemical Society and its authors. Do not 
copy or disclose without written permission. If you have received this item in error, notify the sender and 
delete all copies. 
 
 
 
Artificial Metalloenzymes Based on the Biotin-Streptavidin 
Technology: Challenges and Opportunities 
 
 
Journal: Accounts of Chemical Research 
Manuscript ID ar-2016-00235u.R1 
Manuscript Type: Article 
Date Submitted by the Author: 27-Jul-2016 
Complete List of Authors: Heinisch, Tillmann; University Basel, Chemistry 
Ward, Thomas; University of Basel, Department of Chemistry 
  
 
 
ACS Paragon Plus Environment
Submitted to Accounts of Chemical Research
 1
Artificial Metalloenzymes Based on the Biotin-Streptavidin Technology: 
Challenges and Opportunities 
Tillmann Heinisch and Thomas R. Ward* 
Department of Chemistry, University of Basel, Spitalstrasse 51, CH-4056 Basel, Switzerland 
email: thomas.ward@unibas.ch 
Conspectus 
The biotin-streptavidin technology offers an attractive means to engineer artificial metalloenzymes 
(ArMs). Initiated over fifty years ago by Bayer and Wilchek, the biotin-(strept)avidin techonology 
relies on the exquisite supramolecular affinity of either avidin or streptavidin for biotin. This versatile 
tool, commonly refered to as "molecular velcro", allows to nearly irreversibly anchor biotinylated 
probes within a (strept)avidin host protein. Building upon a visionary publication by Whitesides from 
1978, several groups have been exploiting this technology to create artificial metalloenzymes. For this 
purpose, a biotinylated organometallic catalyst is introduced within (strept)avidin to afford a hybrid 
catalyst that combines features reminiscent of both enzymes and of organometallic catalysts. 
Importantly, ArMs can be optimized by chemo-genetic means. Combining a small collection of 
biotinylated organometallic catalysts with streptavidin mutants allows to generate significant diversity, 
thus allowing to optimize the catalytic performance of ArMs. Pursuing this strategy, the following 
reactions have been implemented: hydrogenation, alcohol oxidation, sulfoxidation, dihydroxylation, 
allylic alkylation, transfer hydrogenation, Suzuki cross-coupling, C-H activation, metathesis. In this 
account, we summarize our efforts in the latter four reactions. X-ray analysis of various ArMs based 
on the biotin-streptavidin technology reveals the versatility and commensurability of the biotin-
binding vestibule to accomodate and interact with transition states of the scrutinized organometallic 
transformations. In particular, streptavidin residues at positions 112 and 121 recurrently lie in the close 
proximity of the biotinylated metal cofactor. This observation led us to develop a streamlined 24-well 
plate streptavidin production and screening platform to optimize the performance of ArMs. 
To date, most of the efforts in the field of ArMs have focused on the use of purified protein samples. 
This seriously limits the throughput of the optimization process. With the ultimate goal of 
complementing natural enzymes in the context of synthetic- and chemical biology, we outline the 
milestones required to ultimately implement ArMs within a cellular enviroment. Indeed, we believe 
that ArMs may allow to signficantly expand the natural enzymes' toolbox to access new-to-nature 
reactivites in vivo. With this ambitious goal in mind, we report on our efforts to i) activate the 
biotinylated catalyst precursor upon incorporation within Sav, ii) minimize the effect of the cellular 
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environment on the ArM’s performance and iv) demonstrate the compatibility of ArMs with natural 
enzymes in cascade reactions. 
 
1 Introduction 
Traditionally, catalysis has been divided into three subdisciplines: heterogeneous-, homogeneous- and 
enzymatic catalysis. In recent years, artificial metalloenzymes (ArMs) have emerged as an attractive 
alternative to complement these. ArMs result from anchoring a metal cofactor within a host protein, 
thereby combining features of both homogeneous catalysts and enzymes. Three strategies have been 
pursued for the creation of ArMs: i) repurposing natural metalloenzymes for abiotic transformation,1–4 
ii) in silico metalloenzyme (re-)design,5–8 and iii) incorporation of abiotic cofactors into proteins.9–16  
Inspired by Whitesides, we and others have exploited the biotin-(strept)avidin technology to localize a 
biotinylated metal cofactor within (strept)avidin.17–20 Optimization of the performance of the resulting 
ArMs is best achieved relying on chemo-genetic means: combining a collection of biotinylated 
organometallic cofactors with a library of streptavidin mutants (Sav hereafter), Scheme 1. Relying on 
this strategy, ArMs based on the biotin-streptavidin technology have been developed for: 
hydrogenation,21,22  allylic alkylation,23 dihydroxylation,24 sulfoxidation,25 alcohol oxidation,26 transfer 
hydrogenation of ketones,27,28 enones29 and imines,30–36 Suzuki cross-coupling,37 C–H activation,38 and 
olefin metathesis.39,40 Whereas our initial focus, summarized in 2011,10 relied on screening using 
purified Sav samples, we outline herein our efforts to adapt this technology to complement natural 
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enzymes in a cellular environment. This ambitious goal was fueled by the tenet that ArMs may be 
used to complement natural enzymes in synthetic biology. 
 
 
 
Scheme 1. Chemogenetic optimization of artificial metalloenzymes based on the biotin-stretpavidin 
technology. Variation of the spacer (blue) between the biotin anchor (green) and the organometallic 
moiety (red) combined with streptavidin mutants (magenta) allows to optimize the performance of 
ArMs. 
To address this challenge, we identified the following milestones: i) develop ArMs for reactions 
absent from the natural enzyme’s repertoire, ii) activate the biotinylated catalyst precursor upon 
incorporation within Sav, iii) minimize the effect of the cellular environment on the ArM’s 
performance and iv) demonstrate the compatibility of ArMs with natural enzymes. 
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2 New-to-nature reactions catalyzed by ArMs 
2.1 Transfer hydrogenation of imines and enones 
Homogeneous asymmetric transfer-hydrogenation was pioneered in the early 1990s by Noyori. For 
this purpose, d6-pianostool complexes bearing an enantiopure 1,2-aminosulfonamide ligand proved 
most efficient.41 Transfer-hydrogenation is a mild alternative to hydrogenation, which catalyzes the 
H2-transfer from an organic donor, typically formate or isopropanol, to a prochiral ketone, imine or 
enone substrate. Despite the abundance of natural keto-reductases, no imine reductase had been 
reported prior to 2011.42 Having demonstrated the versatility of the biotin-streptavidin technology for 
artificial keto-reductases,27,28 we set out to adapt the system for the reduction of imines and activated 
alkenes. 
Tethering a biotin-anchor to an aminosulfonamide ligand (Biot-p-L1 hereafter) allows to localize a 
pianostool within Sav. While for the artificial keto-reductase, [(η6-arene)Ru(Biot-p-L1)Cl]-proved 
most efficient,27,28 the iridium analog [(η5-Cp*)Ir(Biot-p-L1)Cl]  (Cp* = C5Me5) clearly outperformed 
the Ru-complex for the reduction of imines. Initial experiments using [(η5-Cp*)Ir(Biot-p-L1)Cl] C1 · 
WT Sav afforded (R)-salsolidine 1 from the cyclic imine 2 in 57 % ee, Scheme 2.30  
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Scheme 2. Genetic optimization of an artificial imine reductase.  
For the optimization of ArMs, past experience suggested that positions Sav S112 and Sav K121 lie 
closest to a biotinylated cofactor bearing a short spacer.28 Screening a focused library of single- and 
double point mutants in the presence of C1 lead to the identification of highly active and selective 
artificial imine reductases for the production of enantioenriched amines 1 and 3:30  
i) At pH 6.5 and 5 °C C1 · Sav S112A  yielded (R)-1  in 91 % ee and > 100 TON (total 
turnover number) after 24 h.  
ii) C1 · Sav S112K lead to (S)-1 with 78 % ee at 5 °C and pH 7.5. 
iii) Improvement of the kinetic parameters could be achieved upon introduction of alanine 
residues at both S112 and K121 positions: compared to the WT variant, the catalytic 
efficiency of the double mutant C1 · Sav S112A K121A was increased 7.6 fold vs. WT 
for the reduction of prochiral imine 4.33  
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iv) Reducing the catalyst concentration to 17 µM (0.025 mol% loading) yielded > 4’000 TON 
for C1 · Sav S112A. 
IrCp*-based complexes are also known to catalyze the chemoselective reduction of enones.43 We thus 
anticipated that the C1 · Sav may also catalyze the reduction of enones to afford the corresponding 
ketone via 1,4-addition.  
To test this, we designed a cyclohexenone derivative 5 which, upon reduction undergoes spontaneous 
E1cB elimination to afford enone 6, releasing the fluorescent umbelliferone.29 At room temperature 
fluorescence develops only in presence of catalyst C1 · Sav. Strikingly, the reaction proceeds even 
under very dilute conditions: 1 µM C1 and 100 µM substrate. Genetic optimization relying on 
fluorescence led to the identification of Sav K121F (147 AU·min-1 compared to 7.5 AU·min-1 for C1 · 
WT Sav) suggesting that protein-substrate interactions are dominated by aromatic interactions, 
Scheme 3a. 
With in vivo applications in mind, the best C1 · WT Sav was encapsulated into a biocompatible, cell-
penetrating polymersome consisting of block-copolymers poly(2-methyloxazoline)-β-
poly(dimethylsiloxane)-β-poly(2-methyloxazoline) (PMOXA-β-PDMS-β-PMOXA) developed by 
Meier.44 Although less active than the non-encapsulated ArM, the activity could be slightly improved 
upon insertion of a bacterial outer-membrane pore protein F (ompF) into the polymersome, Scheme 
3b. 
Page 6 of 26
ACS Paragon Plus Environment
Submitted to Accounts of Chemical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 7
Scheme 3. Artificial enone-reductase based on the biotin-streptavidin technology a). Encapsulation 
within a polymerosome affords a biocompatible artificial organelle b). 
 
2.2 Abiotic C–C bond forming reactions. 
2.2.1 Introduction Among the numerous abiotic reactions catalyzed by precious metals, C–C bond 
forming reactions have been extensively scrutinized. Importantly, these reactions have no equivalent 
in the enzymatic repertoire and the reagents display limited cross reactivity in a cellular environment 
(i.e. bioorthogonality).45 With the aim of complementing the natural enzyme's repertoire, we thus set 
out to develop ArMs for these reactions. 
2.2.2 An artificial metathase based on the biotin-streptavidin technology. Ring-closing metathesis 
(RCM) is a widely applicable reaction for the intramolecular formation of internal C=C double bonds 
from olefins. One of the most widely used catalysts is the Grubbs-Hoyveda 2nd generation complex. 
Importantly, it is water compatible.46 Following our well-established strategy, we set out to investigate 
and improve the potential of a biotin-bearing Grubbs-Hoyveda second generation complex in the 
presence of (strept)avidin for RCM. We initially synthesized two biotinylated N-heterocyclic carbenes 
and scrutinized their potential to localize the {Ru(alkylidene)}-moiety within (strept)avidin, Scheme 4. 
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In our initial report, the D-biotin anchor was linked to the imidazole moiety of the NHC Grubbs 
Hoyveda 2nd-generation complex: (Biot-L2) and (Biot-m-ABA-L2). For screening purposes, we 
selected the hydrophobic N-tosyl diallyl amine 7. 
Avidin (Avi) proved to be a better host than streptavidin:  [RuCl2(Biot-L
2)(alkylidene)]  · WT Avi 
yielded up to 19 turnovers;  [RuCl2(Biot-m-ABA-L
2)(alkylidene)] · WT Sav afforded  14 TONs, 
Scheme 4. However, the artificial metathase did not outperform the free [RuCl2(Biot-L
2)(alkylidene)]. 
To improve the performance of the artificial metathase, we synthesized a library of biotinylated-NHC 
ligands.40 We could show that two mesityl substituents are required and that the biotin anchor is best 
placed on one of these aryl groups. To overcome the very limited aqueous solubility of substrate 7, we 
used its cationic analog 9. Screening a small library of Sav mutants led to the identification of 
[RuCl2(Biot-L
3)(alkylidene)] C4 · Sav K121A: 66 TON were obtained for the RCM of substrate 9 
(free cofactor C4 affords only 38 TONs, Scheme 4).47  
In stark contrast to the imine reductase, we could show that the artificial metathase is remarkably 
tolerant toward cellular extracts. These observations thus open fascinating perspectives towards RCM 
in vivo. 
Scheme 4. An artificial metathase based on the biotin-streptavidin technology.  
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2.2.3 An artificial Suzukiase. Having previously reported on an artificial allylic alkylase based on a 
biotinylated palladium diphosphine,23 we speculated that it may be possible to extend this strategy to 
Suzuki cross-coupling reactions. We hypothesized that this reaction may be amenable to in vivo 
catalysis, thanks to the bio-orthogonality of both reactants: aryl halides and boronic acids.  
The chemical diversity was achieved by screening a variety of biotinylated NHC ligands (vide supra) 
and biotinylated monophosphines, Scheme 5. In the presence of WT Sav, the [Pd(η3-
cinnamyl)Cl(Biot-L2)] performed poorly whereas the Suzukiase with the bulky and electron-rich 
phosphine [Pd(η3-cinnamyl)Cl(Biot-Et-P(t-Bu)2] C6 · WT Sav and [Pd(η
3-cinamyl)Cl(Biot-Pr-P(t-
Bu)2] C7 · WT Sav afforded the methoxy-binaphtyl 10 with 78 and 73 TONs respectively. The length 
of the spacer had a dramatic influence on the enantioselectivity: (R)-10 (58% ee) was formed 
preferentially with the ethyl spacer and (S)-10 (10% ee) with the propyl spacer. The [Pd(η3-
cinnamyl)Cl(Biot-Et-PPh2)] · WT Sav also afforded the (R)-10 but in lower conversion (42% ee, 45 
TONs). In comparison, the TON was reduced fourfold in the absence of Sav, highlighting the 
favourable environment provided by the protein on the catalytic performance. For genetic optimization 
purposes, both C6 and C7 were screened with a focused library of Sav mutants: up to 90 % ee (R)-10 
was obtained with C6 · Sav S112Y-K121E (50 TONs at 4oC) and 47 % ee, (S)-10 in the presence of 
C6 · Sav K121A, (32 TONs at room temperature). Enantioselective Suzuki-cross coupling in water is 
rare.48 This may be traced back to the propensity of palladium to form highly active achiral 
nanoparticles in water.  
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Scheme 5. An artificial Suzukiase for the sythesis of enantioenriched binaphtyls. Insert: close-up view 
of the X-ray structure of C6 · Sav S112Y-K121E.  
 
3. Protein-accelerated catalysis: precatalyst activation upon incorporation 
within streptavidin 
3.1 Introduction In contrast to evolving natural enzymes in vivo, ArMs rely on exogeneous cofactors 
which must be added to the Sav to form the holoenzyme. More often than not, the biotinylated 
cofactors are active even in the absence of Sav. With the goal of performing catalysis in vivo, we 
speculated that developing an inactive precatalyst that would be activated only upon incorporation 
within Sav would be highly desirable. We selected d6-pianostool complexes as these have shown: i) to 
have a great potential in a variety of homogeneous catalytic transformations49 and ii) promising 
tolerance towards cellular extracts.50 To allow for broad applicability, we introduced a biotin anchor 
on the cyclopentadienyl moiety. Modelling studies revealed that an ethyl spacer between the biotin 
and the Cp*-moiety would place the corresponding complex in the proximity of residues S112 and 
K121 within Sav.35 To investigate the validity of the approach, we selected the Rh-catalyzed C–H 
activation and the ATHase reactions. 
3.2 Biotinylated Rh(III) pianostool complex in engineered streptavidin for accelerated 
asymmetric C–H activation 
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Activation of sp2 C–H bonds by a [(η5-Cp*)RhCl2]2 pianostool catalyst is a powerful tool to 
functionalize arenes with alkyl or vinyl substituents via C–C bond formation.51 Starting from pivaloyl-
protected benzhydroxymic acid 11, isoquinolone 12 is formed upon reaction with mthylacrylate. We 
hypothesized that the artificial benzannulase [(Biot-Et-η5-Cp*)MCl2(H2O)] · Sav might allow to 
control both the regio- and the stereoselectivity of this reaction. Initial experiments with [(Biot-Et-η5-
Cp*)RhCl2(H2O)] C10 · WT Sav revealed good activity and moderate selectivity in the presence of an 
acetate buffer (0.68 M). Indeed, the rate determining step is the Concerted Metallation-Deprotonation 
step (CMD) whereby the N-bound rhodium activates the ortho-Caryl–H bond. In a MeOH : H2O 1 : 4 
mixture, 23 TONs with a 9 : 1 regioisomeric ratio and a 50 % ee in favor of the (R)-isoquinolone 12 
were obtained. The free cofactor afforded 40 TONs with a 4 : 1 regioisomeric ratio and (rac)-12. With 
the aim of activiting the cofactor C10 upon incorporation in Sav, we screened a variety of mutants 
bearing a carboxylate residue in the proximity of the Rh-moiety. We were delighted to observe 
significant amounts of (R)-12 (56 % ee, 45 TON, 15 : 1 regioisomer ratio) in the presence of C10 · 
Sav K121E, even without added base. This suggests that the glutamate acts as a base to deprotonate 
the ortho-Caryl–H bond. In order to improve the enantioselectivity, we screened a variety of Sav 
mutants. Gratifyingly, combining the selective S112Y mutant with the highly active K121E mutant 
yielded a highly active and highly selective benzannulase C10 · Sav S112Y-K121E: (R)-12 could be 
isolated in 82 % ee, 48 TONs and a 19 : 1 regioisomer ratio), Scheme 6a. 
Using an ortho-mono-deuterated benzamide 11, a kinetic isotopic effect (KIE) of 4.8 was determined. 
This confirms that the rate determining step of the benzannulation is the CMD step, Scheme 6b. For 
comparison, C10 · WT Sav had KIE = 2.8. 
Upon varying the Rh : Sav ratio, the rate-enhancing effect of the engineered basic residue at position 
121 was estimated to be 100. 
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Scheme 6. An artificial benzannulase for the synthesis of enantioenriched dihydroisoquinolones. 
Reaction conditions and substrate scope a) and postulated transition state of the CMD step b). 
 
3.3 Activation of a biotinylated Rh(III) pianostool complex by histidine coordination for 
asymmetric transfer hydrogenation  
With the aim of extending the activation strategy outlined for the rhodium-catalyzed C–H activation 
step, we reasoned that the transfer hydrogenation activity of [(Biot-Et-η5-Cp*)MCl2(H2O)] (M = 
Rh(III), Ir(III)) may be significantly enhanced upon coordination to a nucleophilic amino acid. We 
hypothesized that mutants Sav S112H or Sav K121H may bind to [(Biot-Et-η5-Cp*)MCl2(H2O)]. We 
thus compared the activity of [(Biot-Et-η5-Cp*)MCl2(H2O)] in combination with WT Sav, Sav S112H 
or Sav K121H in the asymmetric transfer hydrogenation of imine 2 to afford salsolidine 1. From these 
experiments, the following features emerge:  
i) Upon incorporation of [(Biot-Et-η5-Cp*)MCl2(H2O)] (M = Rh(III), Ir(III)) into WT Sav, both the 
activity and selectivity remained virtually unaffected (rac-1 and 6 % (S)-1 for Rh and Ir respectively).  
ii) Upon incorporation of C10 in Sav S112H, (S)-salsolidine 1 is produced with up to 55 % ee and 
TON > 100 at 55 °C and pH = 5.0, Scheme 7a. 
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iii) In contrast, C10 · Sav K121H affords (R)-salsolidine 1 in 79 % ee and > 100 TON at 55 °C and pH 
= 5.0, Scheme 7a. Upon decreasing the temperature, both the TON and the enantioselectivity 
decreased for both ATHases: for  C10  · Sav K121H, at 25 °C, (R)-salsolidine 1 is produced with TON 
= 12 and ee 50 % (R)-1.  
The histidine-coordination to C10 was confirmed by X-ray crystallography for both ATHases [(Biot-
Et-η5-Cp*)RhCl2(H2O)] · Sav K121H and C10 · Sav S112H. The two structures revealed a pseudo-
mirror image relationship between the two mutants, thus providing a hint as to why the ATHases 
produce (S)- and (R)-salsoline 1 depending on the position of the histidine, Scheme 7b, c. 
Scheme 7. A dual-anchoring strategy for the localization and activation of C10 within streptavidin. 
Genetic optimization of the performance of the ATHase activity a); X-ray structure of C10 · Sav 
S112H b) and C10 · Sav K121H c) revealing the pseudo-mirror image environment around the 
rhodium.  
 
 
 
Page 13 of 26
ACS Paragon Plus Environment
Submitted to Accounts of Chemical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 14
4 High-throughput screening of ArMs: overcoming the streptavidin 
purification bottleneck 
4.1 Neutralizing glutathione To date, most of the effort in the field of ArMs has been centered 
around the use of precious metals.10,52,53 While these metals provide versatile tools towards the 
implementation of new-to-nature reactivities, their soft-character renders them susceptible to 
poisoning via coordination to thiols. In particular, glutathione (GSH hereafter) is typically present in 
mM concentrations in aerobic cells.54 Exploratory experiments with the biotinylated cofactors 
presented above revealed that super-stoichiometric amounts GSH (< 10 equivalents vs. precious metal) 
irreversibly inhibit their catalytic performance. This sets a severe restriction on the prospect of 
screening unpurified protein samples. In stark contrast, the oxidized disulfide form of glutathione 
(GSSG hereafter) is less detrimental to the catalytic performance of the biotinylated metal cofactors. 
We thus set out to evaluate in the presence of [(η5-Cp*)Ir(Biot-p-L1)Cl]-based ATHases (Scheme 2), 
the effect of a selection of known GSH-neutralizing agents, Scheme 8. Initial experiments were 
performed by spiking purified Sav samples with 2.5 mM GSH. The effect of the GSH-neutralizing 
agents was then evaluated in the presence of either C1 · Sav S112A (to produce preferentially (R)-1) 
or  C1 · Sav S112K (to produce preferentially (S)-1). Under these "rehearsal" conditions, diamide 
DiAm, 2-bromo-acetophenone BrPheOne and phenyl-vinylsulfone PheViSul proved most promising, 
Scheme 8. However, the neutralizing agent (5-10 mM) needed to be allowed to react overnight prior to 
the addition of the C1 cofactor. The ATHase activity of C1 · Sav S112A was nearly restored in the 
presence of DiAm (TON > 90 and ee comparable to unspiked samples. For the C1 · Sav S112K, the 
effect of DiAm was less pronounced.34  
Next, the GSH neutralizing agents were tested in the presence of E. coli cell free extracts which 
contained only the soluble fraction of the cell lysate including Sav. Here, DiAm clearly outperformed 
BrPheOne and PheViSul. At 10 mM DiAm and two hours preincubation, > 50 % of the activity 
obtained with purified Sav samples could be recovered with identical enantioselectivity. In the 
presence of cell lysates, the TON and ee for ATHase Sav S112K were nearly identical (64 % residual 
TON and -68 % ee). For ATHase with Sav S112A, 23 % residual TON and 70 % ee were obtained.34  
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Scheme 8. Identification of a suitable glutathione (GSH) neutralizing agent for screening ATHase in 
the presence of E. coli cell-free extracts.  
 
From these studies, we conclude that soluble thiol-containing peptides and proteins are indeed 
inhibitors for C1. Addition of DiAm allows to overcome this limitation and screen cell free extracts.  
 
4.2 Multiwell-plate streptavidin expression Having identified a means to screen E. coli cell-free 
extracts containing Sav isoforms for ATHase activity, it remained to develop a streamlined protocol 
for the parallel expression of the host proteins. 
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Past experience suggests that one milligram of tetrameric streptavidin is sufficient to perform 2-3 
catalytic experiments. Such Sav quantities can routinely be produced in five milliliter E. coli cultures. 
We thus established a 24 deep well-plate expression and screening platform. Inspection of the crystal 
structures of Sav-based ArMs revealed 28 amino acid positions that lie within 15 Å of the metal. 
These were selected for site-directed mutagenesis. Rather than using degenerate codons, a strategy 
relying on precise primers was implemented for the following reasons: i) it limits the screening effort 
as no oversampling is required and ii) it allows to freely select the mutation to be introduced at each 
position. The following amino acid mutations were selected for the twenty eight positions: A, V, L, D, 
E, Q, K, H, M, Y, S, P  to afford 334 Sav isoforms. As the presence of a lysine at position 121 was 
shown to be detrimental both in terms of Sav expression levels and in terms of catalytic performance 
for various ArMs,33,47 the Sav K121A was selected as the background Sav from which all mutations 
were introduced. 
Mutations were introduced using the Quick-change PCR in a 96-well format. Next, point-mutated 
pET24a-SAV vectors were transformed into E. coli BL21 (DE3) and Sav expression was performed in 
24-well format using auto-induction medium ZYP-5052. After 24 h, the cells were harvested by 
centrifugation and lysed to obtain cell lysates. The Sav concentration (i.e. free biotin-binding sites) 
within the cell-lysates or the cell-free extracts was determined by a single point determination using 
biotin-4-fluorescein.47 
Two complementary strategies for ArM screening are pursued in the Ward group: either diamide 
treatment to neutralize GSH or reversible immobilization of sepharose imminobiotin beads. 
For ATHase, the cell-free extracts are treated with diamide DiAm prior to addition of C1 and 
subsequent catalysis in 200 µL total volume. Reaction progress and quantification can readily be 
perfomed by HPLC analysis, Scheme 9 option A.47  
 For metathesis screening, a straightforward Sav immobilization protocol was implemented. The cell-
free extracts containing the Sav isoform are treated with iminobiotin-sepharose at pH = 9. At this pH, 
Sav binds tightly to iminobiotin, thus allowing to remove all other cell-debris by simple 
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centrifugation. Acidification protonates the iminobiotin, thus releasing the semi-purified Sav sample. 
As the metathesis is performed under acidic conditions, ideally pH = 4, the biotinylated cofactor C4 
can be added directly to the immobilized Sav in the reaction buffer, Scheme 9 option B.47  
These protocols are suited for the semi-automated in vitro directed evolution protocols of ArMs based 
on the biotin-avidin technology.  
 
Scheme 9. A streamlined protocol for the production and the screening of streptavidin mutants. 
Diamide treatment for ATHase screening (Option A) and reversible immobilization on iminobiotin-
sepharose for metathase screening (Option B). Adapted with permission from ref. [47]. Copyright 
[2016] [MacMillan]. 
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5 Engineering cascades with artificial metalloenzymes 
5.1 Background Having demonstrated the compatibility of ArMs with cellular components, including 
other enzymes present in cell-free extracts, we set out to investigate the possibility of engineering 
enzyme cascades. In their natural environment, enzymes have evolved to operate in the presence of 
other enzymes, thus rendering these systems ideally suited to engineer cascades. Organometallic 
catalysts and enzymes however often suffer from mutual inhibition. To overcome this challenge, a 
compartmentalization strategy has proven versatile.55,56 We hypothesized that embedding a 
biotinylated organometallic cofactor within Sav may effectively shield it from undesirable interactions 
with a partner enzyme. To test this, we selected the ATHase [(η5-Cp*)Ir(Biot-p-L1)Cl] · Sav and tested 
its compatibility with a variety of natural enzymes.  
5.2. Enzyme cascades relying on amine oxidases and ATHases We initially set out to combine an 
ArM's-catalyzed imine reduction with a natural amine oxidase. The ATHase C1 · Sav S112T, which 
displays modest (R)-selectivity for the imine 4  (59 % ee) was combined with monoaminooxidase-N-9 
(MAO-N-9). This enzyme, displays near perfect (S)-selectivity towards a variety of amines to afford 
the corresponding imines using dioxygen as oxidant.57 In a dynamic kinetic resolution, MAO-N-9 
(re)oxidizes (S)-3 to the corresponding imine 4, leaving the enantiopure amine (R)-3 untouched. Initial 
experiments combining MAO-N-9 and an ATHase were disappointing as the reaction rapidly stalled. 
We speculated that this may be due to the formation of hydrogen peroxide as side product of the 
amine oxidase activity. Addition of a catalase allowed to run concurrent enzyme cascades to afford 
(R)-amines (>99 % ee), starting either from rac-amines or imines. Thanks to its near perfect 
selectivity, the overall enantioselectivity of the enzyme cascade is determined by the MAO-N-9.  
Pursuing a similar enzyme cascade strategy, other enantiopure amines could be prepared, including 
pyrrolidines 15 and 17 as well as pipecolic acid 21, Scheme 10. Interestingly, the tertiary imine 
pseudooxynicotine 16 is reduced to the corresponding (R)-amine 17 with >99 % ee and 65 TON. At 
pH 7.5 pseudooxynicotine 16 is in equilibrium between the ring-open ketone 18 and the imine 16. The 
ATHase based on Sav S112A-K121T is imine 16 selective (76 : 11) to afford nicotine 17 whereas the 
ATHase-based on Sav S112G favours the alcohol 19 (3 : 79), Scheme 10c. The chemoselectivity of 
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ArMs bears great potential which may reveal further similarities between ArMs and natural 
enzymes.31  
 
 
Scheme 10 Enzyme cascades combining an ATHase and an amine oxidase for the synthesis of 
enantiopure amines. Synthesis of isoquinolines and pyrrolidines a,b); nicotine c), and pipecolic acid 
d). Addition of either a horsereddish peroxidase or a catalase prevents the oxidation of the iridium 
cofactor by hydrogen peroxide. 
 
5.3 ATHase for nicotinamide regeneration Although the cost of nicotinamides (NAD(P)H) has 
decreased in recent years, it contributes significantly to the operating costs of NAP(P)H-depedent 
purified enzyme processes. Many enzymatic NAD(P)+-regeneration processes have been reported,58 
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but only few homogeneous organometallic NAD(P)+-regeneration systems have been demonstrated to 
operate in the presence of the NAD(P)H-dependent enzyme.59 Having demonstrated the compatibility 
of [(η5-Cp*)Ir(Biot-p-L1)Cl] · Sav with a variety of oxidases and peroxidases, we tested its versatility 
for the regeneration of nicotinamides, Scheme 11. For this purpose, we selected the NADH-dependent 
hydroxybiphenyl monooxygenase (HbpA) and combined it with C1 · WT Sav. To our delight, 2-
hydroxybiphenyl 22 was converted to 1,2-dihydroxybiphenyl 23 (TON > 99) in the presence of 
dioxygen. In this cascade, water is produced as side product and thus no catalase is required, Scheme 
11.31 Most recently, this strategy was extended to NADH-mimics that are compatible with enoate 
reductases.60 
 
Scheme 11 ATHase-catalyzed regeneration of NAD+ and application in cascades with a 
monooxygenase. 
6 Outlook  
In this account, we have summarized our efforts in the field of ArMs based on the biotin-streptavidin 
technology. Although several other strategies have been pursued,52,53 the versatility of streptavidin to 
consistently afford very good catalytic performances is nearly unrivaled. We hypothesize that this may 
be traced back to the commensurate size and topology of the biotin-binding vestibule to accomodate 
biotinylated organometallic cofactors and their respective substrates. This versatility comes at a price 
however. Indeed, the biotinylated cofactors remain partially exposed to the solvent upon embedding 
within streptavidin. As a result, the influence of the protein on the catalytic performance remains 
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limited: to date, a ten- to a hundred fold improvement in reaction rate could be achieved. The resulting 
catalytic performance thus remains well below those of natural enzymes. To overcome this challenge, 
computational active-site redesign should be combined with high-throughput screening or selection 
schemes. With this long-term goal in mind, we have identified and addressed many of the challenges. 
These are summarized in this account: the in vivo directed evolution of artificial metalloenzymes 
based on the biotin-streptavidin technology thus seems within reach. 
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